Department of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, India
Department of Pharmacy, Uttarakhand Technical University, Dehradun, Uttarakhand, India.
Eur J Hosp Pharm. 2022 Mar;29(e1):e95-e96. doi: 10.1136/ejhpharm-2020-002566. Epub 2020 Dec 18.
A 42-year-old male patient visited the outpatient department for follow-up with a history of respiratory tract infection and diabetes mellitus. His main symptom was peeling of his epidermal layer of skin, and bullous fixed drug eruption on the lower and upper limbs and bank region of the body. Following assessment, the patient was prescribed levothyroxine, hydroxychloroquine, levofloxacin, and a combination of sulfamethoxazole-trimethoprim. On assessing causality of the adverse drug reaction (ADR), different ADR assessment scales such as the WHO-UMC Scale, Naranjo Scale, and Hartwig's Severity Assessment Scale were used, and the ADR was found by these scales to be 'likely', 'moderate', and 'probable', respectively. It was found that ADRs such as bullous fixed drug eruptions are not fatal but can cause patient anxiety and a reduced quality of life. This case report will help physicians and clinicians to become aware and vigilant about the ADR caused by levofloxacin, facilitating its early detection and management.
一位 42 岁男性患者因呼吸道感染和糖尿病就诊于门诊。他的主要症状是下肢和上肢以及躯干部位的表皮层剥落和大疱性固定药物疹。评估后,患者被开了左甲状腺素、羟氯喹、左氧氟沙星和复方磺胺甲噁唑-甲氧苄啶。在评估不良反应(ADR)的因果关系时,使用了不同的 ADR 评估量表,如世界卫生组织-UMC 量表、Naranjo 量表和 Hartwig 严重程度评估量表,这些量表分别发现 ADR 为“可能”、“中度”和“可能”。发现大疱性固定药物疹等不良反应虽不致命,但会引起患者焦虑和降低生活质量。本病例报告将帮助医生和临床医生意识到并警惕左氧氟沙星引起的不良反应,促进其早期发现和管理。